|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/343 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61K 31/00 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/343 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3188727 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15766274.3 |
| Europos patento paraiškos padavimo data | 2015-08-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-11-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/047610 |
| Data | 2015-08-29 |
| (87) | Numeris | WO 2016/036619 |
| Data | 2016-03-10 |
| (30) | Numeris | Data | Šalis |
| 201462044856 P | 2014-09-02 | US | |
| 201562169635 P | 2015-06-02 | US |
| (72) |
LAVEDAN, Christian , US
POLYMEROPOULOS, Mihael, H. , US
|
| (73) |
Vanda Pharmaceuticals Inc. ,
2200 Pennsylvania Ave NW
Suite 300-E, Washington, DC 20037,
US
|
| (54) | TASIMELTEON FOR TREATING SMITH-MAGENIS SYNDROME |
| TASIMELTEON FOR TREATING SMITH-MAGENIS SYNDROME |